mRNA expression profiling of histone modifying enzymes in pediatric acute monoblastic leukemia

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Histone modification plays a crucial role in cancer development.
• Dysregulation of histone-modifying enzymes is observed in various hematological malignancies.
• The specific expression profile of these enzymes in pediatric acute monoblastic leukemia (AML FAB M5) remained uncharacterized.

Purpose of the Study:

• To investigate the mRNA expression profile of histone-modifying enzymes in pediatric AML FAB M5.
• To identify differentially expressed genes and their potential roles in the pathogenesis of AML FAB M5.
• To explore biological interactions and upstream regulators of these enzymes.

Main Methods:

• Utilized a novel real-time PCR array to analyze the expression of 85 histone-modifying enzyme genes.
• Examined mRNA expression in 27 pediatric AML FAB M5 samples.
• Employed Ingenuity Pathway Analysis (IPA) to identify gene networks and upstream regulators.

Main Results:

• Identified a gene signature of 28 differentially expressed genes (15 up-regulated, 13 down-regulated).
• Revealed up-regulated expression of oncogenes (e.g., GCN5L2, SETD8, KDM5C, AURKA, AURKB) and down-regulated expression of tumor suppressor genes (e.g., EP300, PRMT3, PRMT8, NOTCH2).
• Discovered significant gene networks related to gene expression, cancer, and embryonic development, with Rb, CDKN2C, and E2F1 identified as upstream regulators.

Conclusions:

• Provides novel insights into the molecular pathogenesis of pediatric AML FAB M5.
• The identified gene signature highlights potential oncogenes and tumor suppressor genes involved in the disease.
• These differentially expressed genes represent promising targets for diagnostic, prognostic, and therapeutic strategies in pediatric AML.